Dr. Martens (LON:DOCS) Trading Down 1.2% – Here’s What Happened

Dr. Martens plc (LON:DOCS) fell 1.2% on Friday . The company traded as low as GBX 73.90 and last traded at GBX 75.90. 1,248,485 shares were traded during trading, a decline of 85% from the average session volume of 8,174,940 shares. The stock had previously closed at GBX 76.80.

Analyst Ratings Changes

A number of analysts have commented on DOCS shares. Berenberg Bank cut their price target on shares of Dr. Martens from GBX 114 to GBX 110 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 100 price objective on shares of Dr. Martens in a research note on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 105.

Dr. Martens Trading Down 1.2%

The firm’s 50-day moving average price is GBX 70.63 and its 200 day moving average price is GBX 68.91. The company has a market cap of £726.45 million, a price-to-earnings ratio of 31.63, a P/E/G ratio of 6.40 and a beta of 0.24. The company has a current ratio of 2.61, a quick ratio of 1.13 and a debt-to-equity ratio of 108.85.

Dr. Martens (LON:DOCS) last issued its earnings results on Tuesday, May 19th. The company reported GBX 4.20 earnings per share (EPS) for the quarter. The business had revenue of £764.90 million for the quarter. Dr. Martens had a net margin of 3.11% and a return on equity of 6.89%. As a group, equities analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.

Insider Activity

In related news, insider Ije Nwokori acquired 118,516 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were bought at an average price of GBX 72 per share, with a total value of £85,331.52. Also, insider Giles Wilson bought 68,313 shares of Dr. Martens stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of GBX 72 per share, with a total value of £49,185.36. Insiders have bought 300,199 shares of company stock worth $22,061,408 in the last quarter. Company insiders own 2.94% of the company’s stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.